FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 342:1051-1053 April 6, 2000 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Lee, T. H. Related Article by Poldermans, D. PubMed Citation

To the Editor: Poldermans et al. (Dec. 9 issue)¹ reported a reduction in the incidence of death and myocardial infarction after vascular surgery among patients who were pretreated with the beta-blocking drug bisoprolol, as compared with those who were not pretreated. Patients were included in the study if the results of dobutamine echocardiography were positive, indicating a high risk of complications of vascular surgery. The authors predicted that the perioperative event rate in this population would be 28 percent. Patients who did not receive beta-blockers were characterized as receiving "standard care."

Beta-blocker therapy with atenolol before vascular surgery has been . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Auerbach, A. D., Goldman, L. (2002). {beta}-Blockers and Reduction of Cardiac Events in Noncardiac Surgery: Scientific Review. JAMA 287: 1435-1444 [Abstract] [Full Text]  
• Hoey, J. (2002). Can you get tuberculosis twice?. CMAJ 166: 478-478 [Full Text]